Registration Dossier

Administrative data

Endpoint:
short-term repeated dose toxicity: dermal
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
other:

Data source

Materials and methods

Results and discussion

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

Executive summary:

In the 28 - days repeated dose study via oral gavage administration only minor effects at higher doses have been observed.This intrinsic property/toxicity potential can be extrapolated to repeated dermal route administration.